Forget chatbots, Ambani's Reliance wants to own India's entire AI economyReliance Industries is charting a unique AI strategy, aiming to democratise artificial intelligence in India by focusing on affordability a...
19 Jun, 2026, 08.02 PM IST
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
19 Jun, 2026, 11.50 AM IST
L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...
19 Jun, 2026, 07.21 AM IST
Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...
17 Jun, 2026, 03.38 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
17 Jun, 2026, 03.08 PM IST
Public-private projects key to expand access to Kidney care: NephroPlusNephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-b...
17 Jun, 2026, 01.01 AM IST
Just donate blood and get VIP into famous temple. The result is blood bank surplus at local hospitalsA unique program in Madhya Pradesh connects blood donation with VIP darshan at Omkareshwar Jyotirlinga temple. Devotees donating blood rece...
16 Jun, 2026, 02.46 PM IST
AI is everywhere. But which products are truly transforming business?The next wave of business transformation is being driven by AI products that deliver measurable results. The ET Most Innovative AI Product ...
15 Jun, 2026, 01.05 PM IST
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
14 Jun, 2026, 12.28 PM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
12 Jun, 2026, 12.25 PM IST
Hair loss due to soft drinks: Hair transplant surgeon explains whether drinking soda with meals can make you go baldCold drink causing hair loss: Daily cold drink habits might affect hair health. Doctors note a link between sugary beverages and conditions...
12 Jun, 2026, 11.28 AM IST
Customer service no longer a cost centre in AI era: HGS CEO Venkatesh KorlaArtificial intelligence is transforming the business process management sector. Companies are now prioritizing customer experience, moving ...
11 Jun, 2026, 06.00 AM IST
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
10 Jun, 2026, 09.05 AM IST
UK reviewing Palantir's NHS contract amid pressure to use break clauseBritain is reviewing a major contract with American firm Palantir for the National Health Service. The government must decide by early 2027...
09 Jun, 2026, 08.57 PM IST
Indian market at 11% discount to long-term average; Anshul Saigal says it's a buyer's market for 3–5 year investorsMarket confusion presents a rare chance for patient investors. Anshul Saigal believes current valuations offer significant gains for those ...
03 Jun, 2026, 09.37 AM IST
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
03 Jun, 2026, 09.22 AM IST
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
31 May, 2026, 05.00 PM IST